Track the Fortress Biotech, Inc. share price and the full insider trade history of the company, a publicly traded company based in United States. Shares trade on the US market, under the authority of SEC (Form 4). Operating in the Health Care sector, Fortress Biotech, Inc. has recorded 80 public disclosures. Market capitalisation: €111m. The latest transaction was filed on 24 June 2026 (Attribution). Among the most active insiders: ROSENWALD LINDSAY A MD. All data is free.
80
Insider Decl.
n/a
Thresholds
€8m
22 ops.
Buy Volume
€92,941
2 ops.
Sell Volume
42Σ signal
Buys €8m€92,941 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 19,469 of 29,064 companies
40.6
score / 100
Value
14
Quality
68
FCF yld-71%
Earn yld-2.0%
EV/EBITDA·
ROE116%
Gross mgn67%
Net mgn-3.0%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
5,000 shares@ US$7.39420.6% of flowSERIES A CUMULATIVE PERPETUAL PREFERRED STOCKSEC:0001104659-24-079100:0
Canonical exit: 7 Oct 2024 (T+90)
25 of 80 declarations
Acerca de Fortress Biotech, Inc.
Fortress Biotech, Inc. es una empresa centrada en el desarrollo de terapias innovadoras para el tratamiento de enfermedades. Opera principalmente en el sector de la salud y farmacéutico, cotizando en NASDAQ.